−£169k
−143%vs Jul 2024Active10874441Private limited companyCambridge
OXCITAS LIMITED
Significant control: Bipinchandra Patel, Electronrx Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Oxcitas Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Oxcitas Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
OXCITAS LIMITED is an active private limited company (company number 10874441) incorporated on 19 July 2017, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 July 2025, showing net assets of −£169k and cash of £11k, with 1 employee on average. Net assets fell 143% on the prior period (£396k).
Peer position · net assets
By net assets it sits in the bottom quarter of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
02
Ownership and control
- Mr Bipinchandra Patel
- can appoint or remove directors
- Electronrx Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- Mr Bipinchandra Patel
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Gyongyver Julia Kadas
- owns 50–75% of shares
- holds 50–75% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 19 July 20179 yrs ago
- Next accounts due
- 30 April 2027in 186 days
- Confirmation statement due
- 2 August 2027in 280 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£11k
−97%vs Jul 2024Not reported
1
−80%vs Jul 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 July 2025 | −£169k | £11k | £6,916 | — | — | — | 1 |
| 31 July 2024 | £396k | £316k | £81k | — | — | — | 5 |
Cash per employee£11kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-168,559 at 31 July 2025
- Net assets down 25% or more on the prior period-142.5% vs prior period
- Incorporated five or more years agoIncorporated 19 July 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 280 days
- Next accounts duein 186 days
- Accounts period endNet liabilities £169k · small accounts
- Accounts period endNet assets £396k · small accounts
- Incorporated
08
Similar companies in Cambridge
- VIROTHERA LTDCambridge · inc. Jul 2017
- CRITICAL PRESSURE LIMITEDCambridge · inc. Jun 2017
- SOLASCURE LIMITEDCambridge · inc. Jun 2017
- INSMED INNOVATION UK LTDCambridge · inc. Aug 2017
- BLACKHAWK INNOVATION LIMITEDCambridge · inc. Aug 2017
- SHIFT BIOSCIENCE LIMITEDCambridge · inc. May 2017
All companies incorporated on 19 July 2017 · in Jul 2017.
09
Reminders for OXCITAS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.